Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
1988-8-19
|
pubmed:abstractText |
In human fundic glands, famotidine was about 17 times more potent than ranitidine as an inhibitor of histamine - stimulated cAMP generation. This H2-receptor antagonist had no effect on the receptor-adenylate cyclase systems sensitive to PGE2, isoproterenol (beta 2-receptor), VIP and on forskolin-induced activation of the Gs/catalytic units of the membrane-bound enzyme prepared from human fundic glands. In the HGT-1 human gastric cancer cell line, famotidine and ranitidine showed long lasting, irreversible actions probably related to a slow rate of dissociation from the histamine H2-receptor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase,
http://linkedlifedata.com/resource/pubmed/chemical/Famotidine,
http://linkedlifedata.com/resource/pubmed/chemical/Ranitidine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Histamine H2,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0065-4299
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
293-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3394579-Adenylate Cyclase,
pubmed-meshheading:3394579-Epithelium,
pubmed-meshheading:3394579-Famotidine,
pubmed-meshheading:3394579-Gastric Fundus,
pubmed-meshheading:3394579-Humans,
pubmed-meshheading:3394579-Ranitidine,
pubmed-meshheading:3394579-Receptors, Histamine H2,
pubmed-meshheading:3394579-Stomach Neoplasms,
pubmed-meshheading:3394579-Thiazoles
|
pubmed:year |
1988
|
pubmed:articleTitle |
Pharmacological control of the histamine H2 receptor-adenylate cyclase system by famotidine and ranitidine in normal and cancerous human gastric epithelia.
|
pubmed:affiliation |
INSERM U.55, Hôpital Saint-Antoine, Paris, France.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|